3
PRIMARY DOCUMENT
- Filing date
- 13 Jan 2014
- Reporting date
- 06 Jan 2014
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
IOVANCE BIOTHERAPEUTICS, INC. reports
- Company location
- San Carlos, CA
- Fiscal year end
- 31 December
Company
Names, identifiers, and filing context for this profile.
1 identity field
SEC filing record 1 source field available
IOVANCE BIOTHERAPEUTICS, INC. has filed 1,011 SEC EDGAR filings since 29 Jan 2008
SEC filing history
Showing 826-850 of 984 matching filings.
Per page
25
Current page
34
CORRESP
CORRESP filing
- Filing date
- 07 Jan 2014
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
S-1/A
File 333-192649
FORM S-1/A
- Filing date
- 07 Jan 2014
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
SC 13G
File 005-85384
SCHEDULE 13G
- Filing date
- 02 Jan 2014
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
UPLOAD
UPLOAD filing
- Filing date
- 27 Dec 2013
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
144
File 000-53127
FORM 144
- Filing date
- 18 Dec 2013
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
S-1
File 333-192649
FORM S-1
- Filing date
- 04 Dec 2013
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
D
File 021-206402
D filing
- Filing date
- 15 Nov 2013
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
10-Q
File 000-53127
LION BIOTECHNOLOGIES QUARTERLY REPORT
- Filing date
- 14 Nov 2013
- Reporting date
- 30 Sep 2013
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
4
PRIMARY DOCUMENT
- Filing date
- 12 Nov 2013
- Reporting date
- 05 Nov 2013
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
PRIMARY DOCUMENT
- Filing date
- 07 Nov 2013
- Reporting date
- 05 Nov 2013
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
PRIMARY DOCUMENT
- Filing date
- 07 Nov 2013
- Reporting date
- 05 Nov 2013
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
8-K
File 000-53127
LION BIOTECHNOLOGIES CURRENT REPORT
- Filing date
- 06 Nov 2013
- Reporting date
- 05 Nov 2013
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
8-K
File 000-53127
LION BIOTECHNOLOGIES CURRENT REPORT
- Filing date
- 31 Oct 2013
- Reporting date
- 30 Oct 2013
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
10-Q
File 000-53127
LION BIOTECHNOLOGIES FORM 10-Q
- Filing date
- 23 Oct 2013
- Reporting date
- 30 Jun 2013
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
10-Q
File 000-53127
LION BIOTECHNOLOGIES FORM 10-Q
- Filing date
- 23 Oct 2013
- Reporting date
- 31 Mar 2013
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
10-K
File 000-53127
GENESIS BIOPHARMA FORM 10-K 2012
- Filing date
- 23 Sep 2013
- Reporting date
- 31 Dec 2012
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
3
PRIMARY DOCUMENT
- Filing date
- 11 Sep 2013
- Reporting date
- 03 Sep 2013
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SC 14F1
File 005-85384
SCHEDULE 14F-1
- Filing date
- 22 Aug 2013
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
DEF 14C
File 000-53127
DEFINITIVE INFORMATION STATEMENT ON SCHEDULE 14C
- Filing date
- 20 Aug 2013
- Reporting date
- 22 Aug 2013
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
NT 10-Q
File 000-53127
GENESIS BIOPHARMA NOTIFICATION OF LATE FILING
- Filing date
- 15 Aug 2013
- Reporting date
- 30 Jun 2013
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
PRE 14C
File 000-53127
PRELIMINARY INFORMATION STATEMENT
- Filing date
- 09 Aug 2013
- Reporting date
- 15 Aug 2013
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
8-K
File 000-53127
GENESIS BIOPHARMA CURRENT REPORT
- Filing date
- 09 Aug 2013
- Reporting date
- 08 Aug 2013
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SC 13D/A
File 005-85384
SCHEDULE 13D AMENDMENT NO. 2
- Filing date
- 07 Aug 2013
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
3
PRIMARY DOCUMENT
- Filing date
- 01 Aug 2013
- Reporting date
- 24 Jul 2013
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing